Sopheon, the international provider of software, expertise, and best practices for Enterprise Innovation Management, announces today that it has issued and allotted 10,000 ordinary shares of 20 pence each in the capital of the Company (“Ordinary Shares”) in connection with the exercise of share options.
Application has been made for the 10,000 new Ordinary Shares to be admitted to trading on AIM, and dealings are expected to commence on 3 October 2017. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.
The total number of Ordinary Shares in issue following Admission will be 7,463,431. The Company does not hold any shares in treasury. Accordingly, the figure of 7,463,431 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For Further Information Contact:
|Barry Mence, Chairman
Arif Karimjee, CFO
|Sopheon plc||+ 44 (0) 1276 919 560|
|Carl Holmes / Giles Rolls (corporate finance)
Mia Gardener (corporate broking)
|finnCap||+ 44 (0) 20 7220 0500|
Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.